Doctors once thought non-small-cell lung cancer (NSCLC) was one disease. Most people got the same treatment -- chemotherapy (chemo) -- especially if their cancer had spread to other parts of the body.

Translational Lung Cancer Research: “Non-small cell lung cancer: current treatment and future advances.” American Cancer Society: “Can Lung Cancer Be Found Early?” “Recent Advances in ...

The treatment landscape for non–small ... CA209-159 combined trial analysis highlight significant advances in the use of ICIs for resectable NSCLC. Based on the findings, perioperative nivolumab ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to ...

Each year, 50,000 new lung cancer cases are diagnosed in France, with non–small cell lung cancer (NSCLC ... Among the major advances presented at the congress were the findings from the ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

This breakthrough not only advances the treatment of non-small cell lung cancer but also marks a significant milestone in global oncology immunotherapy." "The interim analysis results from the ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical ...

Black Diamond advances NSCLC treatment in Phase 2 trial View all comments ... showing promising clinical responses in patients with relapsed/refractory EGFR-mutant non-small cell lung cancer (NSCLC).

To better understand treatment outcomes ... In a third study, Lunit developed an AI model to identify EGFR-mutant NSCLC tumors with morphologic features similar to small cell lung cancer (SCLC ...

This breakthrough not only advances the treatment of non-small cell lung cancer but also marks a significant milestone in global oncology immunotherapy." ...